Insulin resistance : From clinical diagnosis to molecular genetics. Implications in diabetes mellitus;La résistance à l'insuline : Du diagnostic clinique à la génétique moléculaire. Implications dans le diabète sucré

Bulletin de l'Academie Nationale de Medecine

Volumn 183, Issue 9, 1999, Pages 1761-1777

  Jaffiol, Claude ^a   Rouard, Mathias ^b   Macari, Françoise ^b   Lautier, Corinne ^b   Ait El Mkadem, Samira ^b   Méchaly, Ilana ^b   Brun, Jean Frédéric ^b   Renard, Éric ^b   Cros, Gérard ^b   Bringer, Jacques ^b   Grigorescu, Florin ^a  

^a UNIV MONTPELLIER   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1 PROTEIN; INSULIN RECEPTOR SUBSTRATE-1 PROTEIN; PHOSPHOPROTEIN;

ACANTHOSIS NIGRICANS; AMINO ACID SUBSTITUTION; ANIMAL; BIOLOGICAL MODEL; FEMALE; GENETIC EPISTASIS; GENETICS; HUMAN; INSULIN RESISTANCE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OVARY POLYCYSTIC DISEASE; PHYSIOLOGY; POINT MUTATION; REVIEW;

ACANTHOSIS NIGRICANS; AMINO ACID SUBSTITUTION; ANIMALS; DIABETES MELLITUS, TYPE 2; EPISTASIS, GENETIC; FEMALE; HUMANS; INSULIN RESISTANCE; MODELS, GENETIC; PHOSPHOPROTEINS; POINT MUTATION; POLYCYSTIC OVARY SYNDROME; RECEPTOR, INSULIN;

EID: 0006175437     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. KAHN C.R., VIVENT D., DORIA A. - Genetics of non-insulin dependent (Type II) diabetes mellitus. Annu. Rev. Med., 1996, 47, 509-531.
2. DEFRONZO R.A. Pathogenesis of type 2 diabetes : metabolic and molecular implications for identifying diabetes genes. Diabetes Reviews, 1997, 5, 177-269.
3. TAYLOR S.I., KADOWAKI T., KADOWAKI H., ACCILI D., CAMA A., MCKEON C. - Mutations in insulin receptor gene in insulin-resistant patients. Diabetes-Care, 1990, 13, 257-279.
4. WHITE M.F., MARON R., KAHN C.R. Insulin rapidly stimulates tyrosine phosphorylation of a Mr-185,000 protein in intact cells. Nature (Lond), 1985, 318, 183-186.
5. KAHN C.R. - Insulin action, diabetogenes, and the cause of Type II diabetes. Diabetes, 1994, 43, 1066-1084.
6. FROGUEL P., VAXILLAIRE M., VEHLO G. Genetic and metabolic heterogeneity of maturity-onset diabetes of the young. Diabetes Reviews, 1997, 5, 123-130.
7. KAHN C.R., FLIER J.S., BAR R.S., ARCHER J.A, GORDEN P., MARTIN N.M., ROTH J. - The syndromes of insulin resistance and acanthosis nigricans : insulin receptor disorders in man. N. Engl. J. Med., 1976, 294, 739-745.
8. DONOHUE W.L., UCHIDA I. - Leprechaunism. A Euphemism for a rare familial disorder. J. Pediatrics, 1954, 45, 505-519.
9. SEIP M. - Lipodystrophy and gigantism with associated endocrine manifestations. A new diencephalic syndrome. Acta Paediatr., 1959, 48, 555-574.
10. ALSTRÖM C.H., HALLGREN B., NILSSON L.B. - Retinal degeneration combined with obesity, diabetes mellitus and neurogenous deafness. A specific syndrome (not hitherto described) distinct from the Laurence-Moon-Bardet-Biedl syndrome. Acta Psychiatr. Neurol. Scand., 1959, 34 (Suppl 129), 1-20.
11. HIMSWORTH H.P. Diabetes Mellitus : a differenciation into insulin-sensitive and insulin-insensitive types. Lancet, 1936, I, 127-130.
12. MARTIN B.C., WARRAM J.H., KROLEWSKI A.S. et al. - Role of glucose and insulin resistance in development of type II diabetes mellitus : results of a 25-year follow-up study. Lancet, 1992, 340, 925-929.
13. DUNAIF A. - Insulin resistance and the polycystic ovary syndrome : mechanism and implication for pathogenesis. Endocrine Reviews, 1997, 18, 774-800.
14. BERGMAN R.N., FINEGOOD D.T., ADER M. - Assessment of insulin sensitivity in vivo. Endocrine Reviews, 1985, 6 [1], 45-86.
15. GRIGORESCU F., FLIER J.S., KAHN C.R. - Characterization of binding and phosphorylation defects of erythrocyte insulin receptors in the Type A syndrome of insulin resistance. Diabetes, 1986, 35 [2], 127-138.
16. GRIGORESCU F., FLIER J.S., KAHN C.R. - Defect in insulin receptor phosphorylation in erythrocytes and fibroblasts associated with severe insulin resistance. J. biol. Chem., 1984, 259 [24], 15003-15006.
17. RENARD E., GRIGORESCU F., LAVABRE C., KAHN C.R. Insulin-dependent phosphatidylinositol 3′ kinase activity co-precipitates with insulin receptor in human circulating monocytes. Biochem. Biophys. Res. Comm., 1995, 209, 234-241.
18. GRIGORESCU F. - Analysis of insulin binding data : Clinical applications. In «The Insulin Receptor» (Venter C. and Harrison L.C. Eds), Alan R. Liss, Inc, 1988.
19. MOLLER D., COHEN O., YAMAGUCHI Y., AZZIZ R., GRIGORESCU F., EBERLE A., FLIER J.S. Prevalence of mutations in the insulin receptor gene in subjects with features of the Type A syndrome of insulin resistance. Diabetes, 1994, 43, 247-255.
20. WHITEHEAD J.P., HUMPHREYS P., KROOK A., JACKSON R., HAYWARD A., LEWIS H., SIDDLE K., O'RAHILLY S. Molecular scanning of the insulin receptor substrate 1 gene in subjects with severe insulin resistance. Detection and functional analysis of a naturally occuring mutation in a YMXM motif. Diabetes, 1998, 47, 837-839.
21. ALMID K., BJORBAEK C., VESTERGAARD H., HANSEN T., ECHWALD S., PEDERSEN O. - Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet, 1993, 542, 828-832.
22. SUN X.J., WANG L.M., ZHANG Y., YENUSH L., MYERS M.G., GLASHEEN E., LANE W.S., PIERCE J.H., WHITE M.F. - Role of IRS-2 in insulin and cytokine signalling. Nature (Lond), 1995, 377, 173-177.
23. SIGAL R.J., DORIA A., WARRAM J.H., KROLEWSKI A.S. - Codon 972 polymorphism in the insulin receptor substrate-1 gene, obesity, and risk of noninsulin-dependent diabetes mellitus J. Clin. Endocr. Metab., 1996, 81 [4], 1657-1659.
24. BERNAL D., ALMIND K., YENUSH L., AYOUB M., ZHANG Y., ROSSHANI L., LARSSON C., PEDERSEN O., WHITE M.F. Insulin receptor substrate-2 amino acid polymorphisms are not associated with random type 2 diabetes among Caucasians. Diabetes, 1998, 47, 976-979.
25. LAVAN B., LANE W.S., LEINHARD G.20- The 60-kDa phosphotyrosine protein in insulin treated adipocytes is a new member of the insulin receptor substrate family. J. Biol. Chem., 1997, 272, 11439-11443.
26. LAVAN B.E., FANTIN V.R., CHANG E.T., LANE W.S., KELLER S.R., LEIHARD G.E. - A novel 160-kDa phosphotyrosine protein in insulin-treated enbrionic kidney cells is a new member of the insulin receptor sucstrate family. J. Biol. Chem., 1997, 272, 21403-21407.
27. ALMIND K., FREDERIKSEN S.K., AHLGREN M.G., URHAMMER S., HANSEN T., CLAUSEN J.O., PEDERSEN O. - Common amino acid substitution in insulin receptor substrate-4 are not associated with type II diabetes mellitus or insulin resistance. Diabetologia, 1998, 41, 969-974.
28. BAIER L.J., WIEDRICH C., HANSON R.L., BOOARDUS C. - Variant in the regulatory subunit of phosphatidylinosotol 3 kinase (p85α). Preliminary evidence indicates a potential role of this variant in the acute insulin response and type 2 diabetes in Pima women. Diabetes, 1998, 47, 973-975.
29. TERAUCHI Y., TSUJI Y., SATOH S., MINOURA H., MURAKAMI K., OKUNOA., INUKAI K., ASANO T., KABURAGI Y., UEKI K., NAKAJIMA H., HANAFUSA T., MATSUZAWA Y., SEKIHARA H., YIN Y., BARRETT J.-C., ODA H., ISHIKAWA T., AKANUMA Y., KOMURO I., SUZUKI M., YAMAMURA K., KODAMA T., SUZUKI H., KADOWAKI T. et al. - Increased insulin sensitivity and hypoglycaemia in mice lacking the p85α subunit of phosphoinositide 3-kinase. Nature Genetics, 1999, 21, 230-235.
30. AIT EL MKADEM S., LAUTIER C., MACARI F., MECHALY I., RENARD E., CROS G., BRINGER J., WHITE M.F., GRIGORESCU F. Combined defects in IRS-1 and IRS-2 genes are associated with insulin resistance in polycystic ovarian syndrome. Diabetes, 1999, 48, [Suppl], A436.
31. ROUARD M., MACARI F., BOUIX O., LAUTIER C., BRUN F., LEFEBVRE P., RENARD E., BRINGER J., JAFFIOL C., ORSETTI A., GRIGORESCU F. - Identification of two novel insulin receptor mutations Asp59Gly and Leu62Pro in Type A syndrome of extreme insulin resistance, Biophys. Biochem. Res. Comm., 1997, 234, 764-768.
32. ROUARD M., BASS J., GRIGORESCU F., GARRETT P.J., WARD C.W, LIPKIND G., JAFFIOL C, STEINER D.F., BELL G.I. - Congenital insulin resistance associated with a conformational alteralion in a conserved β-sheet in the insulin receptor L1 domain. J. Biol. Chem., 1999, 274, 18487-18491.
33. ALMIND K., INOUE G., PEDERSEN O., KAHN C.R. - A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. J. Clin. Invest., 1996, 97, 2569-2575.
34. PATTI M.E., KAHN C.R. - Transgenic animal models : insight into the pathophysiology of NIDDM. Diabetes Reviews, 1997, 5, 149-164.
35. ACCILI D., DRAGO J., LEE E.J., JOHNSON M.D., COOL M.H., SALVATORE P., ASICO L.D., JOSE P.A., TAYLOR S.I., WESTPHAL H. 2D Early neonatal homozygous for null allele of the insulin receptor gene. Nature (Genetics), 1996, 12 [1], 106-109.
36. ARAKI E., LIPES M.A., PATTI M.E., BRÜNING J.C., In B.H., JOHNSON R.S., KAHN C.R. Alternative pathway of insulin signaling in mice with targeted disruption of the IRS-1 gene. Nature (Lond), 1994, 372, 186-190.
37. BRÜNING J.C., WINNAY J., BONNER-WEIR S., TAYLOR S.I., ACCILI D., KAHN C. R. - Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell, 1997, 88, 561-572.
38. WHITHERS D.J. et al. - Disruption of IRS-2 causes type 2 diabetic in mice. Nature (Lond). 1998, 391, 900-904.